- VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently being studied in a Phase 1 clinical trial; Phase 2 planned for fourth quarter of 2025 CAMBRIDGE, Mass., May 29, ...

Sodium oxybate is the first oral treatment for laryngeal dystonia to show efficacy at providing temporary relief for debilitating symptoms that impact speaking, according to the results of a Mass Eye ...

Add Yahoo as a preferred source to see more of our stories on Google. When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind.

Jonathan Allen first picked up the trombone in the fourth grade. After playing for years, he eventually earned a doctorate in musical arts and a teaching position at the University of Iowa. Then, one ...

Medically reviewed by Nicholas R. Metrus, MD Tardive dyskinesia and dystonia are movement disorders with different causes and onset of symptoms.Treatment for both disorders may involve anticholinergic ...